期刊文献+

聚维酮对人膀胱癌T24细胞的抑制作用研究 被引量:1

A Study of the Inhibitory Effect of Polyvinylpyrrolidone on Human Urinary Bladder Carcinoma Cells T24 In Vitro
在线阅读 下载PDF
导出
摘要 目的探讨聚维酮(PVP)对人膀胱癌T24细胞的抑制作用。方法采用MTT法检测PVP对T24细胞生长的抑制作用,流式细胞仪检测PVP对T24细胞周期的影响和黏附作用。结果2.5%PVP作用24和72 h,对人膀胱癌T24细胞生长抑制率分别为(15.11±2.36)%和(49.57±7.07)%;浓度为7.5%时24和72 h抑制率分别(35.42±5.55)%和(79.66±19.92)%。5.0%PVP作用24和72 h时,细胞G0/G1期所占比例分别为(74.17±0.91)%和(46.69±3.76)%;G2/M期细胞所占比例分别为(14.63±0.47)%和(41.88±1.50)%。PVP能提高抗鼠IgG1对T24细胞的黏附作用。结论PVP能通过诱导人膀胱癌T24细胞周期阻滞于G2/M期和作为化疗药的黏附性载体而抑制癌细胞的生长增殖。 Objective To probe into the inhibitory effect of polyvinylpyrrolidone (PVP) on human urinary bladder carcinoma cells T24 in vitro. Methods Human urinary bladder carcinoma cells T24 were incubated in medium containing PVP in final concentrations of 2.5%, 5.0% and 7.5%, respectively, for 72 h. The MTr test was used to assay the inhibitory effect of PVP on the T24cells while flow cytometry was adopted to examine the influence of PVP on the cell cycle and adhesive property of the carcinoma cells. Results The inhibition rates of the cell growth were ( 15. 11 ± 2.36) % and (49.57 ± 7.07) %, when the cells had been incubated with 2.5% PVP for 24 and 72 h, respectively. The rates increased to( 35.42 ± 5.55)% and(79.66 ± 19.92)% when the cells had been incubated with 7.5% PVP for 24 and 72 h, respectively. After the T24 cells had been incubated with 5% PVP for 24 and 72 h, the ratios of cells is G0/G1 phase were (74. 17 ± 0.91 ) % and (46.69 ± 3.76) % and those in G2/M phase cells were ( 14.63 ± 0.47) % and (41.88 ± 1.50) %, respectively. 5% PVP could also enhance the effect of murine IgG1 to adhere to the T24 cells. Conclusion PVP was shown to inhibit the growth and proliferation of human urinary bladder carcinoma cells T24 in vitro probably by blocking the cell cycle at the G2/M phase and serving as adhesive carrier of chemotherapeutic agents.
出处 《医药导报》 CAS 2007年第2期124-126,共3页 Herald of Medicine
关键词 聚维酮 膀胱癌 细胞周期 黏附 Polyvinylpyrrolidone Urinary bladder carcinoma, human Cell cycle Adhesion
  • 相关文献

参考文献4

二级参考文献9

  • 1Van Buskirk AM,Braley MH.In vitro activation of specific helper and suppressor T cells by the type 2 antigen polyvinylpyrrolidone(PVP).J Immunol,1987,139:1400-1405.
  • 2Chary RB,Vani G,Rao YM.In vitro and in vivo adhesion testing of mucoadhesive drug delivery systems.Drug Der Ind Pharm,1999,25:685-690.
  • 3Tsunoda S,Kamada H,Yamamoto Y,et al.Molecular design of polyvinylpyrrolidone-conjugated interleukin-6 for enhancement of in vivo thrombopoietic activity in mice.J Control Release,2000,68:335-341.
  • 4Lamm DL.Diagnosis and treatment of bladder cancer.Anticancer Drugs,1992,(suppl 1 ):39-47.
  • 5Pich A,Chiusa L,Formiconi A,et al.Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder.Cancer,2002,95:784-790.
  • 6Santos L,Amaro T,Costa C,et al.Ki-67 index enhances the prognostic accuracy of the urothelial superficial bladder carcinoma risk group classification.Int J Cancer,2003,105:267-272.
  • 7殷晓煜,吕明德,梁力建,赖英荣,黄洁夫,李智.肝癌组织内树突状细胞及淋巴细胞浸润的临床意义[J].中华外科杂志,2002,40(5):336-338. 被引量:17
  • 8殷放宙,蔡宝昌.聚维酮在缓释控释制剂中的应用[J].中成药,2002,24(7):545-547. 被引量:6
  • 9陈彤,郑少斌,谭万龙,李祖国.癌组织树突状细胞浸润与肾癌预后及转移的关系[J].第一军医大学学报,2002,22(9):833-834. 被引量:8

共引文献18

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部